Harbour Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.16K Sell
74
-16
-18% -$933 ﹤0.01% 3654
2025
Q4
$5.35K Sell
90
-2
-2% -$109 ﹤0.01% 2994
2025
Q3
$4.98K Buy
92
+3
+3% +$172 ﹤0.01% 2988
2025
Q2
$4.89K Sell
89
-3
-3% -$177 ﹤0.01% 2887
2025
Q1
$6.5K Sell
92
-3
-3% -$202 ﹤0.01% 2719
2024
Q4
$6.24K Sell
95
-11
-10% -$737 ﹤0.01% 2649
2024
Q3
$7.45K Buy
106
+6
+6% +$502 ﹤0.01% 2481
2024
Q2
$8.23K Sell
100
-155
-61% -$12.9K ﹤0.01% 2339
2024
Q1
$22.3K Buy
255
+11
+5% +$985 ﹤0.01% 1907
2023
Q4
$23.5K Buy
244
+128
+110% +$11.3K ﹤0.01% 1799
2023
Q3
$10.3K Buy
116
+22
+23% +$1.96K ﹤0.01% 2025
2023
Q2
$8.15K Buy
94
+1
+1% +$94 ﹤0.01% 2130
2023
Q1
$9.04K Buy
93
+29
+45% +$3.01K ﹤0.01% 2047
2022
Q4
$6.62K Sell
64
-13
-17% -$1.22K ﹤0.01% 2124
2022
Q3
$6K Hold
77
﹤0.01% 2095
2022
Q2
$6K Buy
+77
New +$6.13K ﹤0.01% 2095
2021
Q4
$11K Sell
123
-1,451
-92% -$120K ﹤0.01% 1875
2021
Q3
$122K Buy
1,574
+124
+9% +$9.78K ﹤0.01% 1265
2021
Q2
$121K Sell
1,450
-4
-0.3% -$317 ﹤0.01% 1297
2021
Q1
$110K Buy
+1,454
New +$119K ﹤0.01% 1253

Other funds holding BMRN